Suzanne E. Clements
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 8
- Genetics 11
- Genetic and rare skin diseases. 6
- Genetic Associations and Epidemiology 5
- Co-authors
- Robin A.P. Weir (11 shared papers)Henry J. Dargie (11 shared papers)Tracey Steedman (11 shared papers)John J.V. McMurray (10 shared papers)Ashley M. Miller (4 shared papers)Iain B. McInnes (4 shared papers)Colin J. Petrie (8 shared papers)Grace Murphy (1 shared paper)
- Journals
- The Lancet (6 papers)Nature (4 papers)Cytokine (2 papers)International Journal of Obesity (2 papers)Circulation Heart Failure (2 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Suzanne E. Clements
39 papers receiving 3.7k citations
Suzanne E. Clements's Hit Papers
Peers
Comparison fields: 5 of 112
- Infectious Diseases 1.8k
- Genetics 597
- Cardiology and Cardiovascular Medicine 418
- Applied Microbiology and Biotechnology 36
- Immunology 218
Countries citing papers authored by Suzanne E. Clements
This map shows the geographic impact of Suzanne E. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne E. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne E. Clements more than expected).
Fields of papers citing papers by Suzanne E. Clements
This network shows the impact of papers produced by Suzanne E. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne E. Clements. The network helps show where Suzanne E. Clements may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne E. Clements, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 4 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 5 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 252 |
| 6 | 2010 | 236 | |
| 7 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 8 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 9 | 2021 | 213 | |
| 10 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 11 | 2008 | 113 | |
| 12 | 2013 | 91 | |
| 13 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 14 | 2010 | 69 | |
| 15 | 2023 | 60 | |
| 16 | 2009 | 53 | |
| 17 | 2010 | 48 | |
| 18 | 2009 | 33 | |
| 19 | 2010 | 32 | |
| 20 | 2009 | 26 |
About Suzanne E. Clements
Suzanne E. Clements is a scholar working on Infectious Diseases, Genetics, Cardiology and Cardiovascular Medicine, Cell Biology and Radiology, Nuclear Medicine and Imaging, having authored 39 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (9 papers), COVID-19 Clinical Research Studies (8 papers), Genetic and rare skin diseases. (6 papers), Genetic Associations and Epidemiology (5 papers), Cardiac Imaging and Diagnostics (4 papers), Skin and Cellular Biology Research (3 papers), Dermatology and Skin Diseases (2 papers) and Cardiovascular Function and Risk Factors (2 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Genetics (597 citations), Cardiology and Cardiovascular Medicine (418 citations), Applied Microbiology and Biotechnology (36 citations) and Immunology (218 citations). Suzanne E. Clements has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Robin A.P. Weir, Henry J. Dargie, Tracey Steedman, John J.V. McMurray, Ashley M. Miller, Iain B. McInnes, Colin J. Petrie, Grace Murphy, John Connell and John Alexander McGrath. Their work appears in journals such as The Lancet, Nature, Cytokine, International Journal of Obesity and Circulation Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.